Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cladribine use trend in Latin America: the changes in patient profile impact in the drug effectiveness.
Silva BA, Heriz A, Ayerbe J, Lázaro L, Casas M, López P, Tkachuk V, Balbuena ME, Nadur D, Liwacki S, Luetic G, Burgos M, Casales F, Piedrabuena A, Carnero Contentti E, Zárate A, Zanga G, Steinberg J, Mainella C, Tavolini D, Hryb J, Leguizamón F, Pagani Cassará F, José G, Carrizo P, Nofal P, Luis B, Pita C, Míguez J, Alonso R. Silva BA, et al. Among authors: tavolini d. Neurol Sci. 2024 Dec;45(12):5841-5848. doi: 10.1007/s10072-024-07763-7. Epub 2024 Sep 11. Neurol Sci. 2024. PMID: 39259243
Clinical effectiveness of dimethyl fumarate in multiple sclerosis patients from Argentina.
Carnero Contentti E, Alonso R, Silva B, Burgos M, Tavolini D, Lopez P, Cristiano E, Patrucco L, Tkachuk V, Mainella C, Zanga G, Leguizamón F, Luetic G, Silva E, Tizio S, Alonso Serena M, Rojas JI. Carnero Contentti E, et al. Among authors: tavolini d. Neurol Sci. 2024 Dec;45(12):5833-5840. doi: 10.1007/s10072-024-07712-4. Epub 2024 Jul 31. Neurol Sci. 2024. PMID: 39080156
Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM).
Carnero Contentti E, Lopez PA, Patrucco L, Cristiano E, Miguez J, Silva B, Liwacki S, Tkachuk V, Balbuena ME, Vrech C, Deri N, Correale J, Marrodan M, Ysrraelit MC, Fiol M, Leguizamon F, Luetic G, Tavolini D, Mainella C, Zanga G, Burgos M, Hryb J, Barboza A, Lazaro L, Alonso R, Fernández Liguori N, Nadur D, Martinez A, Steinberg J, Carrá A, Alonso Serena M, Rojas JI. Carnero Contentti E, et al. Among authors: tavolini d. Mult Scler Relat Disord. 2024 Sep;89:105771. doi: 10.1016/j.msard.2024.105771. Epub 2024 Jul 20. Mult Scler Relat Disord. 2024. PMID: 39033591
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina.
Rojas JI, Alonso R, Luetic G, Patrucco L, Casas M, Silva B, Miguez J, Deri N, Vrech C, Liwacki S, Piedrabuena R, Silva E, Tkachuk V, Burgos M, Tavolini D, Zanga G, Pinheiro AA, Hryb J, Leguizamon F, Knorre E, Lopez PA, Martinez A, Carrá A, Alonso Serena M, Cristiano E, Correale J, Garcea O, Fernandez Liguori N, Carnero Contentti E. Rojas JI, et al. Among authors: tavolini d. Clin Neuropharmacol. 2024 Jul-Aug 01;47(4):120-127. doi: 10.1097/WNF.0000000000000598. Epub 2024 May 22. Clin Neuropharmacol. 2024. PMID: 39008542
Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study.
Carnero Contentti E, Lopez PA, Pettinicchi JP, Miguez J, Patrucco L, Cristiano E, Liwacki S, Tkachuk V, Balbuena ME, Vrech C, Deri N, Correale J, Marrodan M, Ysrraelit MC, Leguizamon F, Luetic G, Tavolini D, Mainella C, Zanga G, Burgos M, Hryb J, Barboza A, Lazaro L, Alonso R, Fernández Liguori N, Nadur D, Alonso Serena M, Caride A, Rojas JI. Carnero Contentti E, et al. Among authors: tavolini d. J Neurol Sci. 2024 Jul 15;462:123099. doi: 10.1016/j.jns.2024.123099. Epub 2024 Jun 14. J Neurol Sci. 2024. PMID: 38897155
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry.
Piedrabuena MA, Correale J, Fiol M, Marrodan M, Rojas JI, Alonso M, Pappolla A, Miguez J, Patrucco L, Cristiano E, Vrech C, Cohen L, Alonso R, Silva B, Luetic G, Deri N, Burgos M, Liwacki S, Piedrabuena R, Tkachuk V, Barboza A, Martinez A, Balbuena ME, Pinheiro AA, Nofal P, Lopez PA, Tavolini D, Leguizamon F, Hryb JP, Tizio S, Recchia L, Reich E, Contentti EC, Marcilla MP, Pagani F, Cabrera LM, Curbelo MC, Mainella C, Liguori NF, Coppola M, Pettinicchi JP, Carra A, Jose G, Nadur D, Bestoso S, Pestchanker C, Vazquez GD, Martinez CM, Ysrraelit MC. Piedrabuena MA, et al. Among authors: tavolini d. J Neurol Sci. 2024 Jun 15;461:123052. doi: 10.1016/j.jns.2024.123052. Epub 2024 May 16. J Neurol Sci. 2024. PMID: 38797140
Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings.
Pestchanker C, Bertado Cortez B, Lana Peixoto MA, Gortari JI, Castro Suarez S, Caparo Zamalloa C, Galiana G, Peñalver F, Daccach Marques V, Messias K, Galleguillos L, García F, Rojas JI, Patrucco L, Cristiano E, Tkachuk V, Liwacki S, Correale J, Marrodan M, Ysraelit MC, Vrech C, Deri N, Leguizamon F, Tavolini D, Mainella C, Zanga G, Alonso Serena M, Ciampi E, Neto HRS, Lopez P, Carnero Contentti E. Pestchanker C, et al. Among authors: tavolini d. J Neurol. 2024 Jul;271(7):4292-4299. doi: 10.1007/s00415-024-12371-8. Epub 2024 Apr 17. J Neurol. 2024. PMID: 38630312
Burden of treatment and quality of life in relapsing remitting multiple sclerosis patients under early high efficacy therapy in Argentina: Data from the Argentinean registry.
Rojas JI, Carnero Contentti E, Alonso R, Tavolini D, Burgos M, Federico B, Patrucco L, Cristiano E. Rojas JI, et al. Among authors: tavolini d. Mult Scler Relat Disord. 2024 May;85:105543. doi: 10.1016/j.msard.2024.105543. Epub 2024 Mar 16. Mult Scler Relat Disord. 2024. PMID: 38520948
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina.
Carnero Contentti E, López PA, Pappolla A, Alonso R, Silva B, Deri N, Balbuena ME, Burgos M, Luetic G, Alvez Pinheiro A, Cabrera M, Hryb J, Nofal P, Pestchanker C, Vrech C, Tavolini D, Tkachuk V, Zanga G, Marrodan M, Ysrraelit MC, Correale J, Carrá A, Federico B, Garcea O, Fernandez Liguori N, Patrucco L, Cristiano E, Giunta D, Alonso Serena M, Rojas JI; on behalf RelevarEM. Carnero Contentti E, et al. Among authors: tavolini d. Neurol Sci. 2024 Feb;45(2):379-389. doi: 10.1007/s10072-023-07282-x. Epub 2023 Dec 30. Neurol Sci. 2024. PMID: 38159147
36 results